Talphera, Inc. (TLPH)
1.08
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
1.08
0.00 (0.00%)
After-Hours: 20:00
Talphera EPS Diluted (Quarterly) : -0.0571 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0571 |
| March 31, 2026 | -0.0366 |
| December 31, 2025 | -0.0563 |
| September 30, 2025 | -0.107 |
| June 30, 2025 | -0.101 |
| March 31, 2025 | -0.0987 |
| December 31, 2024 | -0.0713 |
| September 30, 2024 | -0.1279 |
| June 30, 2024 | -0.1461 |
| March 31, 2024 | -0.1599 |
| December 31, 2023 | -0.2459 |
| September 30, 2023 | -0.081 |
| June 30, 2023 | -0.4001 |
| March 31, 2023 | -0.7483 |
| December 31, 2022 | -1.002 |
| September 30, 2022 | -0.9402 |
| June 30, 2022 | 8.58 |
| March 31, 2022 | -1.191 |
| December 31, 2021 | -1.24 |
| September 30, 2021 | -1.405 |
| June 30, 2021 | -1.654 |
| March 31, 2021 | -1.582 |
| December 31, 2020 | -1.933 |
| September 30, 2020 | -2.032 |
| June 30, 2020 | -1.638 |
| Date | Value |
|---|---|
| March 31, 2020 | -3.978 |
| December 31, 2019 | -3.625 |
| September 30, 2019 | -3.204 |
| June 30, 2019 | -3.146 |
| March 31, 2019 | -3.471 |
| December 31, 2018 | -3.556 |
| September 30, 2018 | -4.152 |
| June 30, 2018 | -4.00 |
| March 31, 2018 | -4.552 |
| December 31, 2017 | -4.00 |
| September 30, 2017 | -5.60 |
| June 30, 2017 | -5.80 |
| March 31, 2017 | -6.80 |
| December 31, 2016 | -4.20 |
| September 30, 2016 | -5.00 |
| June 30, 2016 | -4.80 |
| March 31, 2016 | -5.00 |
| December 31, 2015 | -4.535 |
| September 30, 2015 | 2.20 |
| June 30, 2015 | -4.00 |
| March 31, 2015 | -5.40 |
| December 31, 2014 | -6.40 |
| September 30, 2014 | -2.60 |
| June 30, 2014 | -6.00 |
| March 31, 2014 | -4.40 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Omeros Corp. | 0.1476 |
| Hyperion DeFi, Inc. | 0.9232 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.312M |
| Total Expenses (Quarterly) | 4.312M |
| Enterprise Value | 45.48M |
| Earnings Yield | -23.80% |
| Normalized Earnings Yield | -22.24 |